Also known as: 1910s European cannabis writing · Edwardian cannabis literature · Early 20th-century European cannabis discourse

Cannabis Literature in Western Europe During the 1910s

Medical texts and policy documents replaced literary Orientalism as the dominant frame for European cannabis writing.

Automated fact-check pass
6 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

The 1910s was not a golden age of European cannabis literature—it was a bureaucratic one. Romantic hashish writing from the 1860s was dead. What replaced it: pharmacy handbooks, colonial medical reports, and diplomats debating whether to schedule the drug. If you've read confident claims about a 'vibrant 1910s cannabis scene,' you're probably reading speculation. The real material is boring but honest.

Context: What 'Cannabis Literature' Meant in 1910

By 1910, Western European writing about cannabis was overwhelmingly medical and pharmaceutical rather than literary or recreational. The romantic era of hashish writing—exemplified by Baudelaire's Les paradis artificiels (1860) and Théophile Gautier's accounts of the Club des Hashischins—had ended half a century earlier [1]. What replaced it was a steady accumulation of pharmacopoeia entries, dispensatory notes, and colonial medical reports Strong evidence. Cannabis indica extract and tincture remained listed in the British Pharmacopoeia and equivalent national pharmacopoeias as a sedative, hypnotic, and analgesic, though clinicians repeatedly documented inconsistent potency Strong evidence.

The 1910s therefore marks a genuine transition: the Orientalist frame was receding, the clinical and bureaucratic frame was rising, and prohibition was being drafted but not yet legally enacted. Understanding this decade requires reading what Europeans actually wrote—dry pharmacological prose—rather than projecting backward from later myths.

Pharmacopoeias and Medical Handbooks

The most widely consulted cannabis texts of the decade were reference works. Sir William Martindale's Extra Pharmacopoeia, issued in successive editions throughout the 1910s, listed Extractum Cannabis Indicae and Tinctura Cannabis Indicae with dosing guidance and explicit warnings about inconsistent strength Strong evidence. These entries standardised how British practitioners approached cannabis dosing—a practical concern for physicians dealing with variable plant material.

In Germany, Louis Lewin, the Berlin pharmacologist, was actively publishing toxicological and pharmacological research throughout the 1910s. His meticulous studies of psychoactive substances laid the groundwork for his 1924 synthesis Phantastica: Die betäubenden und erregenden Genussmittel, which would become the standard German-language reference on cannabis and other drugs for decades Strong evidence[3]. Lewin's approach—systematic, non-moralistic, empirical—shaped how educated European readers understood cannabis pharmacology.

None of these texts treat cannabis as a major public-health crisis; they treat it as a moderately useful, awkwardly inconsistent medication. This reflects the clinical reality of the time: cannabis was in use, tolerated in medical practice, and not yet constructed as a threat.

Colonial and Administrative Reports

European writing on cannabis in the 1910s was shaped heavily by colonial administration. The Indian Hemp Drugs Commission Report (1894), commissioned by the British government to assess cannabis use across India, remained influential in English-language medical and policy circles through the 1910s Strong evidence[4]. Its cautious empirical conclusion—that moderate, regulated use caused little demonstrable harm—was cited by British physicians and administrators as evidence against restrictive policy.

French administrators in North Africa (Algeria, Morocco, Tunisia) produced reports on local kif and hashish use that circulated in metropolitan medical journals, though typically as short notices rather than sustained book-length analyses. Similarly, Dutch colonial officials documented cannabis preparations in the East Indies (ganja, marihuana), and these records entered Dutch pharmaceutical and administrative literature. This entire body of work was administrative in tone and purpose: focused on prevalence, social stability, and tax or regulatory frameworks rather than chemistry or subjective pharmacology.

The 1912 Hague Convention and Policy Literature

The International Opium Convention, signed at The Hague on 23 January 1912, is the pivotal policy document of the decade for drug history generally Strong evidence[5]. Cannabis ('Indian hemp') was not included in the main list of scheduled substances. The Italian delegation raised the question of cannabis control; it was tabled for further study rather than brought to a binding vote Disputed[5].

The published Actes and proceedings of the conference are crucial primary sources for understanding how cannabis was diplomatically framed in this period: as a regional concern (primarily colonial), not yet a target of international control. This framing reflected the reality that cannabis use and trafficking, while present across Europe and the colonial world, had not yet been constructed as an international emergency. That construction would follow in the 1920s, when the 1925 Geneva Convention added cannabis to the international drug schedule, hardening the trajectory toward global prohibition Strong evidence.

Genuinely literary cannabis writing in 1910s Western Europe is sparse—and this is where myths most often accumulate. Modern writers frequently project the Club des Hashischins into the 1910s as evidence of a 'vibrant hashish literary scene,' but the club itself had dissolved by the 1850s [1]. Occasional references to hashish appear in fin-de-siècle and early modernist fiction, but no major 1910s European novel or poem is built around cannabis in the way Baudelaire's or Gautier's earlier work was Weak / limited.

Walter Benjamin's well-known hashish protocols—the diary entries and reflections that shaped 20th-century literary cannabis culture—were not written until 1927–1934 and should not be retrofitted onto the 1910s Strong evidence[6]. If you encounter confident claims about a vibrant Edwardian or wartime European cannabis literary scene, ask for specific citations. The documentary base is thin.

What Didn't Exist: Anachronisms to Avoid

Several concepts modern readers assume are rooted in the 1910s are actually anachronistic:

THC and cannabinoid chemistry: THC was not isolated until 1964 by Raphael Mechoulam and Yechiel Gaoni Strong evidence. No 1910s text discusses THC, potency by percentage, or molecular structure. CBD was isolated in 1940. Any 1910s writing about cannabis 'strength' refers to subjective effects or loose descriptors like 'mild' or 'strong' extract, not to cannabinoid content.

'Indica vs sativa' as effect predictor: This distinction is a late-20th-century marketing convention, not an Edwardian botanical or pharmacological claim. See Indica vs Sativa for the history of this folk taxonomy.

'Reefer madness' moral panic: The style of moral panic associated with cannabis—claims of violence, psychosis, and degeneration driven by a single substance—is a 1930s American phenomenon, particularly tied to Harry Anslinger's Federal Bureau of Narcotics campaigns. It is not characteristic of 1910s European writing Strong evidence. The decade is interesting precisely because it sits before these later frames hardened.

How to Read 1910s Sources Today

If you want to engage with this material directly, the practical entry points are:

Pharmacological texts: Digitised editions of the British Pharmacopoeia (multiple 1910s editions) and Martindale's Extra Pharmacopoeia are held by the Wellcome Collection and Internet Archive. These show how cannabis was officially classified, dosed, and used in practice.

Colonial and government reports: The Indian Hemp Drugs Commission Report (full text widely available online) remains the most substantial empirical document from the period. The Actes of the 1912 Hague Conference, held by League of Nations archive successors and digitised through the United Nations Office on Drugs and Crime, document the diplomatic treatment of cannabis at the international level.

German-language pharmacology: Readers of German should examine Lewin's journal articles from the 1910s, which are scattered through toxicology and pharmacology journals; these lay the groundwork for Phantastica.

What to expect: Dry, technical prose; inconsistent terminology (chanvre indien, Indian hemp, haschisch, Cannabis indica often used interchangeably); and a near-total absence of the recreational-culture framing that dominates modern writing. The tone is clinical, administrative, or scholarly—never promotional, never moral panic.

Sources

How this page was made

Generation history

Oct 31, 2026
Fact-check pass — raised 10 flags
Oct 31, 2026
Revision
Jun 25, 2026
Fact-check pass — raised 2 flags
Jun 25, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.